Related Experiment Videos
Staphylococcal scalded skin syndrome developing during burn treatment
The Journal of Dermatology
|December 6, 2001
Summary
A 5-year-old girl developed staphylococcal scalded skin syndrome (SSSS) during burn treatment. Prompt antibiotic treatment led to recovery, highlighting the need to understand asymptomatic carriers for infection prevention.
Area of Science:
- Pediatrics
- Dermatology
- Infectious Diseases
Background:
- Staphylococcal scalded skin syndrome (SSSS) is a skin blistering disease caused by exfoliative toxins from Staphylococcus aureus.
- Hospital-acquired infections are a concern in pediatric burn units.
Observation:
- A 5-year-old girl hospitalized for burn treatment developed SSSS following an upper respiratory tract infection.
- Clinical presentation included extensive erythema, exfoliation, and purulent discharge from the burn ulcer.
- Staphylococcus aureus producing exfoliative toxin A (ETA) was isolated from the patient's nasopharynx and skin lesions.
Findings:
- The patient was diagnosed with SSSS based on clinical and laboratory findings.
- Antibiotic therapy resulted in the subsidence of SSSS symptoms.
- The source of infection, suspected to be an asymptomatic carrier, could not be identified despite investigation.
Implications:
- This case underscores the potential for SSSS as a hospital-acquired infection in vulnerable pediatric patients.
- Further research into the prevalence of asymptomatic carriers of ETA-producing strains is crucial.
- Developing effective strategies to prevent SSSS in healthcare settings is necessary.